Lyra Therapeutics Inc
NASDAQ:LYRA

Watchlist Manager
Lyra Therapeutics Inc Logo
Lyra Therapeutics Inc
NASDAQ:LYRA
Watchlist
Price: 8.55 USD 0.23% Market Closed
Market Cap: 13.7m USD

Wall Street
Price Targets

LYRA Price Targets Summary
Lyra Therapeutics Inc

Wall Street analysts forecast LYRA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LYRA is 23.46 USD with a low forecast of 16.16 USD and a high forecast of 31.5 USD.

Lowest
Price Target
16.16 USD
89% Upside
Average
Price Target
23.46 USD
174% Upside
Highest
Price Target
31.5 USD
268% Upside
Lyra Therapeutics Inc Competitors:
Price Targets
UCB
Ucb SA
24% Upside
DRREDDY
Dr Reddy's Laboratories Ltd
4% Upside
ABBOTINDIA
Abbott India Ltd
6% Upside
600216
Zhejiang Medicine Co Ltd
12% Upside
200670
Humedix Co Ltd
5% Upside
PFE
Pfizer Inc
19% Upside

Revenue
Forecast

Revenue Estimate
Lyra Therapeutics Inc

The compound annual growth rate of Lyra Therapeutics Inc's revenue for the next 3 years is 115%.

N/A
Past Growth
115%
Estimated Growth
Estimates Accuracy
-42%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Lyra Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Lyra Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-54%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LYRA's stock price target?
Price Target
23.46 USD

According to Wall Street analysts, the average 1-year price target for LYRA is 23.46 USD with a low forecast of 16.16 USD and a high forecast of 31.5 USD.

What is Lyra Therapeutics Inc's Revenue forecast?
Projected CAGR
115%

The compound annual growth rate of Lyra Therapeutics Inc's revenue for the next 3 years is 115%.

Back to Top